Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Significant Accounting Policies (Details)

v3.21.1
Significant Accounting Policies (Details) - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Sep. 30, 2020
Accounting Policies [Abstract]        
Foreign currency transaction $ 181 $ 230    
Net income     $ 176  
Research and development expenses   $ 28 $ 327  
Transaction price 5,000      
Reimbursement cost $ 1,000      
Option exercise       $ 3,000
Income tax percentage 50.00%      
Warrants exercisable (in Shares) 4,008,007 3,536,495 2,299,684